Clinical Trials Browser

Phase NA × Myelodysplastic Syndromes × Azacitidine × Clear all

NCT02489929 2015-07-03

Evaluation of Cytidine Deaminase for Patient Suffering of a Myelodysplastic Syndrom or an AML Treated by Azacytidine

Phase NA Unknown

MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Myelodysplastic Syndromes